Objectives: Breast cancer is the most common malignancy in women in the Kaiser Permanente Northwest Region. Ninety-five percent of women later found to have breast cancer were seen an average of 5 times in the medical offices in the year preceding diagnosis. Until 1991, screening mammography depended on clinician ordering. However, 20% of at-risk women were left out of the process because they had no clinician visit in the preceding year. Self-referral mammography was introduced as one of a number of processes to provide more comprehensive screening.
Methods: The Region’s tumor registry database was examined to assess the effect of self-referral screening on early diagnosis, stage of disease, and family history.
Results: From 1991 to 2010, more than 995,000 mammograms were performed and 8752 breast cancers were diagnosed. By 2011, almost 50% of all mammograms were scheduled using the self-referral process, with more than 25% of cancers diagnosed through this process that year. The tumor registry provided both active and passive roles in the quality of cancer screening.
Discussion: The expected result of improving access to screening has been demonstrated over the last two decades. Beginning with the self-referral mammography program, each successive effort enhanced overall organizational effectiveness of care for the average-risk patient but failed to translate into any improvements for the higher-risk patients. As the number of screening tests done is used as the sole measure of screening effectiveness, segments of the at-risk population are likely to be missed, compromising overall early detection efforts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951030 | PMC |
http://dx.doi.org/10.7812/TPP/13-038 | DOI Listing |
ACS Biomater Sci Eng
January 2025
Nano 2 Micro Material Design Lab, Department of Chemical Engineering and Technology, IIT (BHU), Varanasi 221005, India.
Herein, fluorescent calcium carbonate nanoclusters encapsulated with methotrexate (Mtx) and surface functionalized with chitosan (25 nm) (@Calmat) have been developed for the imaging and treatment of triple-negative breast cancer (TNBC). These biocompatible, pH-sensitive nanoparticles demonstrate significant potential for targeted therapy and diagnostic applications. The efficacy of nanoparticles (NPs) was evaluated in MDA-MB-231 TNBC cell lines.
View Article and Find Full Text PDFDalton Trans
January 2025
CEQUINOR (UNLP, CCT-CONICET La Plata, asociado a CIC), Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Blvd. 120 No. 1465, La Plata (1900), Argentina.
In this work, we evaluated the anticancer activity of compounds 1 (mononuclear) and 2 (dinuclear) copper(II) coordination compounds derived from the ligand 5-methylsalicylaldehyde 2-furoyl hydrazone (H2L) over MDA-MB-231 Triple-negative breast cancer (TNBC) cells, and compared their activities with that of a newly synthesized, protonated, dinuclear analogue of 2 (complex 3). Here, we report the synthesis of compound 3 and it has been characterized in the solid state (X-ray diffraction, FTIR) and in solution (EPR, UV-Vis, ESI) as well as its electrochemical profile. Complexes 1-3 impaired cell viability from 0.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
S-SPIRE Center, Department of Surgery, Stanford University School of Medicine, Stanford, California.
Importance: Transportation insecurity and lack of social support are 2 understudied social determinants of health that contribute to excess morbidity, mortality, and acute health care utilization. However, whether and how these social determinants of health are associated with cancer screening has not been determined and has implications for preventive care.
Objective: To determine whether transportation insecurity or social support are associated with screening adherence for colorectal, breast, and cervical cancer.
JAMA
January 2025
Fred Hutch Comprehensive Cancer Center, University of Washington, Seattle.
JAMA
January 2025
Institut Jules Bordet, l'Université Libre de Bruxelles and Hôpital Universitaire de Bruxelles, Brussels, Belgium.
Importance: Triple-negative breast cancer is an aggressive subtype with a high incidence in young patients, a high incidence in non-Hispanic Black women, and a high risk of progression to metastatic cancer, a devastating sequela with a 12- to 18-month life expectancy. Until recently, one strategy for treating early-stage triple-negative breast cancer was chemotherapy after surgery. However, it was not known whether the addition of immune therapy to postsurgery chemotherapy would be beneficial.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!